XAF1 as a modifier of p53 function and cancer susceptibilityEmília M. Pinto, Michael R. Clay, Wenan Chen et al.|Science Advances|2020Cited by 58
Complete Clinical Response in Stage IVB Endometrioid Endometrial Carcinoma after First-Line Pembrolizumab Therapy: Report of a Case with Isolated Loss of PMS2 ProteinJesus Paula Carvalho, Filomena Marino Carvalho, Auro del Giglio et al.|Case Reports in Oncology|2020Cited by 8